The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India. Correction to Ruling Number N258062.

N259753 December 12, 2014 CLA-2-30:OT:RR:NC:2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9135 Mr. Peter van de Beek BluePoint Laboratories Eastgate Business Park Eastgate Park, Building 1 Little Island, Cork Ireland RE: The tariff classification of Bupropion Hydrochloride Extended Release Tablets, imported in dosage form, from India. Correction to Ruling Number N258062. Dear Mr. van de Beek: This replaces Ruling Number N258062, dated November 5, 2014, which contained a mistake of fact. In your original ruling request, you inadvertently described the subject product as containing the active ingredient Bupropion. You now state that the active ingredient is, in fact, Bupropion Hydrochloride. A complete corrected ruling follows: In your letter dated October 9, 2014, you requested a tariff classification ruling. The subject product, Bupropion Hydrochloride Extended Release Tablets, imported in 300 mg tablet form, is a medicinal preparation containing, Bupropion Hydrochloride, a norepinephrine-dopamine reuptake inhibitor, as the active ingredient. It is indicated for the treatment of major depressive disorder.The applicable subheading for the Bupropion Hydrochloride Extended Release Tablets imported in dosage form will be 3004.90.9135, HTSUS, which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Antidepressants, tranquilizers, and other psychotherapeutic agents.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Gwenn Klein Kirschner Director National Commodity Specialist Division